Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
Recruiting
Phase 1
Interventional Study
Chronic Kidney Diseases
Renal Transplantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Qianfoshan Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of remimazolam (CNS 70754) in healthy adult participants. The main questions it aims to answer are:
What are the key pharmacokinetic parameters of remimazolam, including peak concentration (Cmax), time to peak concentration (Tmax), area under the curve (AUC), and elimination half-life (T1/2)? What i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria Signed informed consent
Age ≥18 years and \<65 years
Chronic renal failure scheduled for renal transplantation
Body mass index (BMI) 18-30 kg/m² (inclusive)
Weight ≥50 kg (males) or ≥45 kg (females)
ASA physical status classification III or IV
Exclusion Criteria Hepatic, psy…
Contacts